SamanTree Medical Raises CHF 9.5 Million to Assess the Margins in Cancer Surgery
Following the promising clinical results achieved with its CE mark device, SamanTree Medical has recently closed a CHF 9.5 Million Series A…
CE Mark for Histolog™ Scanner new version
Latest version of the Histolog™ Scanner obtained the CE Mark for compliance with European Directives. The product has been upgraded to suit…
H2020 EU grant for market entry
European Innovation Council of the European Union supports Histolog™ Scanner market entry with €2.3 millions grant, via its H2020 SME's…
FIT loan to support market entry
SamanTree Medical has been granted a loan of CHF 400’000 by the Foundation for Technological Innovation (FIT) to support the Histolog…
The Histolog™ Scanner presented at the ParisBreast Rendez-Vous 2018
SamanTree Medical is pleased to announce that the Histolog™ Scanner will be showcased to the breast surgeon community during the "Paris…
SamanTree Medical wins PERL 2018 edition
SamanTree Medical wins 2018 edition of the Prix Entreprendre Région Lausanne (PERL). Etienne Shaffer (CTO) and Bastien Rachet (CEO).…
3rd place at Strategis Prize 2018
SamanTree Medical is proud to announce that it has earned the 3rd place award of the Prix Strategis 2018. Awarded every year by HEC Espace…
4th place at the Swiss Medtech Award 2018
We are pleased to announce that SamanTree Medical has been part of the 7 Swiss Medtech companies shortlisted for the Swiss Medtech Award…
Breast cancer study results presented at EBCC-11
SamanTree Medical is pleased to announce the presentation of the study on breast biopsies featuring great results on breast cancer…
Interview with Bastien Rachet, SamanTree Medical’s CEO
What if you could bring high quality microscopy to the operating room? SamanTree Medical, a Swiss firm, is trying to do that with its…